scholarly journals Marginalized Knowledge: An Agenda for Indigenous Knowledge Develop-ment and Integration with Other Forms of Knowledge

2007 ◽  
Vol 7 ◽  
pp. 236-245
Author(s):  
Dennis Ocholla
Keyword(s):  
Indigenous Knowledge ◽  
Brain Drain ◽  
Ethical Issues ◽  
Education And Training ◽  
Evaluation Use ◽  
And Training ◽  
Legal And Ethical Issues ◽  
Forms Of Knowledge

The purpose of this paper is to re-examine Indigenous Knowledge (IK) in order to suggest an agenda for its development and integration with other forms of knowledge. The paper discusses what marginalization of IK mean, examines the challenges of integrating IK in the mainstream of other forms of knowledges and sug-gests agenda for IK development. The suggested agenda focuses on mapping and auditing IK capacity in Africa, legal and ethical issues, IK management, IK education and training, integration of IK and KM, IK brain drain. The paper recommends that information on IK be widely shared for evaluation, use and further devel-opment.

scholarly journals Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective

2021 ◽  
pp. 147775092110341
Author(s):  
Mojtaba Vaismoradi ◽  
Cathrine Fredriksen Moe ◽  
M Flores Vizcaya-Moreno ◽  
Piret Paal
Keyword(s):  
Ethical Issues ◽  
Medication Administration ◽  
Ethical Considerations ◽  
Medicines Management ◽  
Ethical Perspective ◽  
Unethical Practices ◽  
Incapacitated Patients ◽  
Pro Re Nata ◽  
And Training ◽  
Legal And Ethical Issues

The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration. There is a lack of integrative knowledge and insufficient understanding regarding ethical considerations surrounding the administration of pro re nata medications to incapacitated patients. Therefore, they have been discussed in this paper and practical strategies to avoid unethical practices have been suggested. The complicated caring situation surrounding the administration of pro re nata medications is intertwined with ethical issues affecting the consideration of the patient's wishes and interventions that override them. The patient's right of autonomy and treatment refusal, surrogacy role, paternalism, and coercion are the main ethos of ethical pro re nata medication administration. Education and training can help nurses avoid legal and ethical issues in pro re nata medicines management and improve the quality and safety of healthcare. Empirical research is needed to improve our understanding of this phenomenon in the multidisciplinary environment of medicines management.

Developing Ethical Competence in Health Care Organizations

2007 ◽  
Vol 14 (6) ◽  
pp. 825-837 ◽  
Author(s):  
Sofia Kälvemark Sporrong ◽  
Bengt Arnetz ◽  
Mats G. Hansson ◽  
Peter Westerholm ◽  
Anna T. Höglund
Keyword(s):  
Health Care ◽  
Training Program ◽  
Moral Distress ◽  
Ethical Issues ◽  
Organizational Factors ◽  
Education And Training ◽  
Financial Strain ◽  
Evaluation Instrument ◽  
Structured Education ◽  
And Training

Increased work complexity and financial strain in the health care sector have led to higher demands on staff to handle ethical issues. These demands can elicit stress reactions, that is, moral distress. One way to support professionals in handling ethical dilemmas is education and training in ethics. This article reports on a controlled prospective study evaluating a structured education and training program in ethics concerning its effects on moral distress. The results show that the participants were positive about the training program. Moral distress did not change significantly. This could be interpreted as competence development, with no effects on moral distress. Alternatively, the result could be attributed to shortcomings of the training program, or that it was too short, or it could be due to the evaluation instrument used. Organizational factors such as management involvement are also crucial. There is a need to design and evaluate ethics competence programs concerning their efficacy.

Counseling Deaf and Hard-of-Hearing Clients

2017 ◽  
pp. 713-718
Author(s):  
Barrie Morganstein
Keyword(s):  
Clinical Practice ◽  
Cultural Identity ◽  
Assistive Technology ◽  
Hard Of Hearing ◽  
Ethical Issues ◽  
Therapeutic Services ◽  
Specialized Population ◽  
And Training ◽  
Legal And Ethical Issues

This chapter focuses on developing a clinical practice with Deaf and Hard-of-Hearing individuals. Providing therapeutic services to this specialized population requires knowledge and training in many areas. While the linguistic implications are most obvious, clinicians must also take into account assistive technology, legal and ethical issues, and cultural identity, to name only a few. The author, a psychologist who has trained and practiced extensively with these individuals, describes her practice with this population, including training for, building, and marketing this niche. Developing a practice that understands and meets the needs of deaf and hard-of-hearing individuals can be challenging and rewarding. The chapter also provides a list of resources.

Engaging pharmacogenomics in pain management and opioid selection

2021 ◽  
Author(s):  
David R Bright ◽  
Natasha Petry ◽  
Eric Roath ◽  
Tyler Gibb
Keyword(s):  
Public Health ◽  
Ethical Issues ◽  
Economic Research ◽  
Successful Implementation ◽  
Opioid Misuse ◽  
Opioid Use ◽  
Health Crisis ◽  
Public Health Crisis ◽  
And Training ◽  
Legal And Ethical Issues

Opioid misuse and mismanagement has been a public health crisis for several years. Pharmacogenomics (PGx) has been proposed as another tool to enhance opioid selection and optimization, with recent studies demonstrating successful implementation and outcomes. However, broad engagement with PGx for opioid management is presently limited. The purpose of this Perspective is to highlight a series of barriers to PGx implementation within the specific context of opioid management. Areas of advancement needed for more robust pharmacogenomic engagement with opioids will be discussed, including clinical and economic research needs, education and training needs, policy and public health considerations, as well as legal and ethical issues. Continuing efforts to address these issues may help to further operationalize PGx toward improving opioid use.

Sign in / Sign up

Export Citation Format

Share Document